Natera: Managing Disease Via Genetic Sequencing

July 2 -- Matthew Rabinowitz, chief executive officer at Natera, explains the process of detecting diseases via genetic testing and the investment of money from his company’s initial public offering. He speaks on “Bloomberg Markets.”